NCT03526289 (GASOLIN II) is a NA clinical trial of GIP1-42 infusion in Type 2 Diabetes Mellitus, sponsored by University Hospital, Gentofte, Copenhagen.

Who is sponsoring NCT03526289?

NCT03526289 is sponsored by University Hospital, Gentofte, Copenhagen.

What drugs are being tested in NCT03526289?

Interventions in NCT03526289: GIP1-42 infusion, Saline.

What condition does NCT03526289 study?

NCT03526289 studies Type 2 Diabetes Mellitus, Overweight and Obesity.

Is NCT03526289 still recruiting?

NCT03526289 is currently completed. Last updated 5 December 2018.

Last reviewed 2018-12-05 · How we verify

NCT03526289: GASOLIN II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake

Completed NA Last updated 5 December 2018

What this trial tests

NA trial testing GIP1-42 infusion in Type 2 Diabetes Mellitus in 22 participants. Completed in 24 October 2018.

Timeline

8 November 2017

Primary endpoint
24 October 2018

24 October 2018

Quick facts

Lead sponsor	University Hospital, Gentofte, Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	22
Start date	8 November 2017
Primary completion	24 October 2018
Estimated completion	24 October 2018
Sites	1 location across Denmark

Drugs / interventions tested

GIP1-42 infusion — full drug profile →
Saline

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University Hospital, Gentofte, Copenhagen

Who can join

Adults 18 to 70, male only, with Type 2 Diabetes Mellitus or Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the study is to evaluate how GIP receptor activation influence food intake and mechanisms regulating food intake in obese individuals with type 2 diabetes that are in steady treatment with metformin and a GLP-1 receptor agonist.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

58<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.
· 2022 · cited 6× · PMID 35920845 · DOI 10.1007/s00125-022-05755-w

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other University Hospital, Gentofte, Copenhagen trials

Trials by the same sponsor.

NCT07171723 — Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment · Phase 1, PHASE2 · recruiting
NCT06934473 — Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals · NA · recruiting
NCT06845033 — Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity · NA · not yet recruiting
NCT06787001 — Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity · completed
NCT06881459 — The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526289 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Gentofte, Copenhagen
Last refreshed: 5 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing